Navigation Links
Medix Uses Globalpark to Glean Insights From Over 20,000 Opinion Leaders
Date:9/21/2010

Medix Uses Globalpark to Glean Insights From Over 20,000 Opinion Leaders -- LONDON, September 21, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Electronics, Computer Software, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Contracts, Surveys, Polls and Research Click to view news release full screen  

Medix Uses Globalpark to Glean Insights From Over 20,000 Opinion Leaders

 

LONDON, September 21, 2010 /PRNewswire/ -- Globalpark (http://www.globalpark.com), a leading provider of panel community and survey software, has become the preferred feedback management platform for leading independent market research consultancy, Medix. By using Globalpark technology, the company is able to measure the opinions of a niche audience - healthcare professionals - on a range of topics and thus provide valuable custom research to its pharmaceutical clients.

Working with Globalpark ensures the company can effectively manage a 20,000+ member research panel to glean accurate insights from a hard to reach niche audience. It also allows the research team at Medix to enjoy a more flexible approach in building questionnaires, fielding across multiple languages, and performing data analysis in real time. "Using Globalpark has been extremely beneficial to Medix. It allows easy management of a large panel featuring members of numerous professions, as well as helping us to meet the research needs of our clients with flexible and rapid data collection and results production," commented Rino Coladangelo Chief Executive.

Healthcare in and of itself continues to be a hot topic globally, and there has been a surge of activity to better understand the market dynamics. "Medix has done an astounding job gaining access to a group of people that are notoriously difficult to reach - we are happy to play a part in that," comments Alex Wilke, Managing Director at Globalpark UK Ltd.

About Globalpark

Globalpark provides panel community and survey software that enables organizations to manage what matters across the enterprise. By capturing feedback and tracking behaviour of customers, employees and partners, they gain insights that drive better business decisions. By identifying and empowering influential advocates, they build reputation and extend reach.

Founded in 1999, Globalpark software is German-engineered and globally-tested by leading brands and top market research institutes, including: Continental, Daimler, General Mills, GfK, IDG, Nintendo, Sony Music, TNS and Warner Music. Globalpark is staffed by renowned research pioneers, with offices across the US, UK, Germany and Austria


'/>"/>
SOURCE Globalpark
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd.
2. Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedixs $20.7 Million Equity Financing
3. Webcast Alert: Cytomedix Inc (GTF) Announces the LHA Life Sciences & Med Tech Day 2010 Presentation
4. Protein Research Marketing Insights
5. European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
6. Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights
7. Museomics yields new insights into extinct Tasmanian tiger
8. New Study Shares Insights for Competitive Intelligence Policies, Ethics and Data Collection
9. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
10. New Insights into the Mechanism of Action of Antipsychotic Drugs
11. Life sticks: UC San Diego bioengineers sticky insights published in journal Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... NC (PRWEB) , ... March 27, 2017 , ... ... Clinical Trial Collaborations (CTC) conference presented by The Conference Forum in Boston on ... way they collaborate to drive improved clinical trial outcomes and bring them closer to ...
(Date:3/27/2017)... 2017 Neurotrope, Inc. (OTCQB: NTRP),  a ... diseases, including Alzheimer,s disease, today announced that it ... the Company,s common stock on the NASDAQ Capital ... Market, a unit of the NASDAQ OMX Group. ... Opening Bell at the NASDAQ MarketSite in Times ...
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
Breaking Biology News(10 mins):